Implantable radiation sensor
This article was originally published in The Gray Sheet
Raleigh, N.C.-based Sicel Technologies announces April 12 clearance of its DVS dose verification system, a wireless, implantable radiation sensor and reader, the first of its kind in the U.S. Tested on breast cancer patients, the dime-sized DVS pinpoints the target tumor and measures radiation dosage to the site. Sicel anticipates launching the product in the third quarter and hopes to expand treatment indications to other cancers soon...
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.